FoxBio, created by Antoxerene and Juvenescence, will develop Antoxerene's collection of small molecules that target senescent cells - cells that cause diseases, such as cancer, as people age.
FoxBio Headquarter Location
Predict your next investment
The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.
Expert Collections containing FoxBio
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
FoxBio is included in 2 Expert Collections, including Biopharmaceuticals.
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.